Cross-fund · 4 holders
URGN
UROGEN PHARMA LTD
CUSIP M96088105
4
Tracked holders
$73.8M
Aggregate value
3,972,412
Shares
4
Active funds
Funds holding URGN
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $51.2M | — | +244,558 | +9.4% |
| Vanguard | Institutional | Q4 2025 | $10.3M | — | +135,966 | +44.8% |
| Millennium | Multi-Strategy | Q1 2026 | $6.7M | — | -248,054 | -40.1% |
| Citadel | Multi-Strategy | Q1 2026 | $5.7M | — | -505,961 | -61.5% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.